Top Markets
Coin of the day
NFL Biosciences S.A. NFL Biosciences S.A.

NFL Biosciences S.A.

ALNFL
Rangering i aksjer #31448
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL... Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.
Aksjekurs
$1.02
Markedsverdi
$12.96M
Endring (1 dag)
-0.92%
Endring (1 år)
-43.11%
Land
FR
Handel NFL Biosciences S.A. (ALNFL)

Kategori

EPS for NFL Biosciences S.A. (ALNFL)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til NFL Biosciences S.A. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for NFL Biosciences S.A. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter